UNIVERSITÉ D'AIX-MARSEILLE
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 24 Total Citation Count
- Jul 30, 2009 Earliest Filing
- 4 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9695247 Antibodies directed against ICOS for treating graft-versus-host diseaseSep 03, 13Jul 04, 17[A61K, C07K]
9441213 Constructs and methods for the production and secretion of polypeptidesApr 09, 14Sep 13, 16[C07H, C12P, C12N, C07K]
9156800 Analogues of porphyrins, their method of preparation and use thereofSep 02, 13Oct 13, 15[H01L, C07F, C07D, H01G]
8735133 Constructs and methods for the production and secretion of polypeptidesJul 30, 09May 27, 14[C07H, C12P, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0319,306 BIOPROCESSING LIGNO-CELLULOSE INTO ETHANOL WITH RECOMBINANT CLOSTRIDIUMAbandonedJun 24, 16Nov 03, 16[C12P, C12N]
2015/0105,352 COMBINATION OF AN HMG-COA REDUCTASE INHIBITOR AND A FARNESYL-PYROPHOSPHATASE SYNTHASE INHIBITOR FOR THE TREATMENT OF DISEASES RELATED TO THE PERSISTENCE AND/OR ACCUMULATION OF PRENYLATED PROTEINSAbandonedDec 18, 14Apr 16, 15[A61K]
2013/0316,961 TREATMENT OF MECP-2 ASSOCIATED DISORDERSAbandonedOct 24, 11Nov 28, 13[A61K, C07D, C07C, C07K]
2013/0115,669 BIOPROCESSING LIGNO-CELLULOSE INTO ETHANOL WITH RECOMBINANT CLOSTRIDIUMAbandonedJan 09, 13May 09, 13[C12P, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.